Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Rebinyn
(https://rebinyn.com) 📸 Data Snapshot: June 19, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Take Control of Hemophilia B | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated (https://rebinyn.com)
Take Control of Hemophilia B | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
Rebinyn® is an injectable treatment used to replace clotting Factor IX in people with hemophilia B. It can be used as routine prophylaxis to reduce the number of bleeding episodes. Read important safety & prescribing info.
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Contact a Novo Nordisk Representative | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated (https://rebinyn.com/help/contact-reps.html)
Contact a Novo Nordisk Representative | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
Novo Nordisk representatives are a great source for information and support. Reps can also connect you to a variety of community resources and product support to help you manage your hemophilia B. Read important safety & prescribing info.
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Safety Considerations | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated (https://rebinyn.com/safety-considerations.html)
Safety Considerations | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
Stay informed on the safety considerations of Rebinyn®, and its manufacturing. Learn about side effects, studies, and safety profile (inhibitors & blood clots). Read important safety & prescribing info.
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Elevate Factor Levels | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated (https://rebinyn.com/why/high-factor-levels.html)
Elevate Factor Levels | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
See how Rebinyn® elevates coagulation factor levels for those with Hemophilia B. Learn about fixed dosing – no adjustments for minor / moderate bleeds. Read important safety & prescribing info.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://rebinyn.com) Take Control of Hemophilia B | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
[H2] Selected Important Safety Information What is the most important information I need to know about Rebinyn®? Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®. Who should not use Rebinyn®? Do not use Rebinyn® if you: are allergic to Factor IX or any of the other ingredients of Rebinyn®. are allergic to hamster proteins. [H2] Indications and Usage What is Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated? Rebinyn® is an injectable medicine used to replace clotting Factor IX that is missing in patients with hemophilia B. Rebinyn® is used to treat, prevent, or reduce the frequency (number) of bleeding episodes in people with hemophilia B. Your healthcare provider may give you Rebinyn® when you have surgery. Rebinyn® is not used for immune tolerance therapy. [H2] Important Safety Information What is the most important information I need to know about Rebinyn®? Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®. Who should not use Rebinyn®? Do not use Rebinyn® if you: are allergic to Factor IX or any of the other ingredients of Rebinyn®. are allergic to hamster proteins. What should I tell my healthcare provider before using Rebinyn®? Tell your healthcare provider if you: have or have had any medical conditions. take any medicines, including non-prescription medicines and dietary supplements. are nursing, pregnant, or plan to become pregnant. have been told you have inhibitors to Factor IX. How should I use Rebinyn®? Rebinyn® is given as an infusion into the vein. Call your healthcare provider right away if your bleeding does not stop after taking Rebinyn®. Do not stop using Rebinyn® without consulting your healthcare provider. What are the possible side effects of Rebinyn®? Common side effects include infusion site reaction (bruising, bleeding, swelling, pain, or redness), itching, and rash. Your body can also make antibodies called “inhibitors” against Factor IX, including Rebinyn®, which may stop Rebinyn® from working properly. Your healthcare provider may need to test your blood for inhibitors from time to time. Call your healthcare provider right away or get emergency treatment right away if you get, for example, any of the following signs of an allergic reaction: hives, chest tightness, wheezing, difficulty breathing, and/or swelling of the face. You may be at an increased risk of forming blood clots in your body, especially if you have risk factors for developing blood clots. Call your healthcare provider if you have chest pain, difficulty breathing, leg tenderness, or swelling. Animals given repeat doses of Rebinyn® showed Polyethylene Glycol (PEG) in certain cells in the brain. The potential human implications of these animal tests are unknown. Please click here for Rebinyn® Prescribing Information. Rebinyn® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
SUB-PAGE (https://rebinyn.com/help/contact-reps.html) Contact a Novo Nordisk Representative | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
[H2] Selected Important Safety Information What is the most important information I need to know about Rebinyn®? Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®. Who should not use Rebinyn®? Do not use Rebinyn® if you: are allergic to Factor IX or any of the other ingredients of Rebinyn®. are allergic to hamster proteins. [H2] Indications and Usage What is Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated? Rebinyn® is an injectable medicine used to replace clotting Factor IX that is missing in patients with hemophilia B. Rebinyn® is used to treat, prevent, or reduce the frequency (number) of bleeding episodes in people with hemophilia B. Your healthcare provider may give you Rebinyn® when you have surgery. Rebinyn® is not used for immune tolerance therapy. [H2] Important Safety Information What is the most important information I need to know about Rebinyn®? Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®. Who should not use Rebinyn®? Do not use Rebinyn® if you: are allergic to Factor IX or any of the other ingredients of Rebinyn®. are allergic to hamster proteins. What should I tell my healthcare provider before using Rebinyn®? Tell your healthcare provider if you: have or have had any medical conditions. take any medicines, including non-prescription medicines and dietary supplements. are nursing, pregnant, or plan to become pregnant. have been told you have inhibitors to Factor IX. How should I use Rebinyn®? Rebinyn® is given as an infusion into the vein. Call your healthcare provider right away if your bleeding does not stop after taking Rebinyn®. Do not stop using Rebinyn® without consulting your healthcare provider. What are the possible side effects of Rebinyn®? Common side effects include infusion site reaction (bruising, bleeding, swelling, pain, or redness), itching, and rash. Your body can also make antibodies called “inhibitors” against Factor IX, including Rebinyn®, which may stop Rebinyn® from working properly. Your healthcare provider may need to test your blood for inhibitors from time to time. Call your healthcare provider right away or get emergency treatment right away if you get, for example, any of the following signs of an allergic reaction: hives, chest tightness, wheezing, difficulty breathing, and/or swelling of the face. You may be at an increased risk of forming blood clots in your body, especially if you have risk factors for developing blood clots. Call your healthcare provider if you have chest pain, difficulty breathing, leg tenderness, or swelling. Animals given repeat doses of Rebinyn® showed Polyethylene Glycol (PEG) in certain cells in the brain. The potential human implications of these animal tests are unknown. Please click here for Rebinyn® Prescribing Information. Rebinyn® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
SUB-PAGE (https://rebinyn.com/safety-considerations.html) Safety Considerations | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
[H2] Selected Important Safety Information What is the most important information I need to know about Rebinyn®? Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®. Who should not use Rebinyn®? Do not use Rebinyn® if you: are allergic to Factor IX or any of the other ingredients of Rebinyn®. are allergic to hamster proteins. [H2] Indications and Usage What is Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated? Rebinyn® is an injectable medicine used to replace clotting Factor IX that is missing in patients with hemophilia B. Rebinyn® is used to treat, prevent, or reduce the frequency (number) of bleeding episodes in people with hemophilia B. Your healthcare provider may give you Rebinyn® when you have surgery. Rebinyn® is not used for immune tolerance therapy. [H2] Important Safety Information What is the most important information I need to know about Rebinyn®? Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®. Who should not use Rebinyn®? Do not use Rebinyn® if you: are allergic to Factor IX or any of the other ingredients of Rebinyn®. are allergic to hamster proteins. What should I tell my healthcare provider before using Rebinyn®? Tell your healthcare provider if you: have or have had any medical conditions. take any medicines, including non-prescription medicines and dietary supplements. are nursing, pregnant, or plan to become pregnant. have been told you have inhibitors to Factor IX. How should I use Rebinyn®? Rebinyn® is given as an infusion into the vein. Call your healthcare provider right away if your bleeding does not stop after taking Rebinyn®. Do not stop using Rebinyn® without consulting your healthcare provider. What are the possible side effects of Rebinyn®? Common side effects include infusion site reaction (bruising, bleeding, swelling, pain, or redness), itching, and rash. Your body can also make antibodies called “inhibitors” against Factor IX, including Rebinyn®, which may stop Rebinyn® from working properly. Your healthcare provider may need to test your blood for inhibitors from time to time. Call your healthcare provider right away or get emergency treatment right away if you get, for example, any of the following signs of an allergic reaction: hives, chest tightness, wheezing, difficulty breathing, and/or swelling of the face. You may be at an increased risk of forming blood clots in your body, especially if you have risk factors for developing blood clots. Call your healthcare provider if you have chest pain, difficulty breathing, leg tenderness, or swelling. Animals given repeat doses of Rebinyn® showed Polyethylene Glycol (PEG) in certain cells in the brain. The potential human implications of these animal tests are unknown. Please click here for Rebinyn® Prescribing Information. Rebinyn® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
SUB-PAGE (https://rebinyn.com/why/high-factor-levels.html) Elevate Factor Levels | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
[H2] Selected Important Safety Information What is the most important information I need to know about Rebinyn®? Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®. Who should not use Rebinyn®? Do not use Rebinyn® if you: are allergic to Factor IX or any of the other ingredients of Rebinyn®. are allergic to hamster proteins. [H2] Indications and Usage What is Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated? Rebinyn® is an injectable medicine used to replace clotting Factor IX that is missing in patients with hemophilia B. Rebinyn® is used to treat, prevent, or reduce the frequency (number) of bleeding episodes in people with hemophilia B. Your healthcare provider may give you Rebinyn® when you have surgery. Rebinyn® is not used for immune tolerance therapy. [H2] Important Safety Information What is the most important information I need to know about Rebinyn®? Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®. Who should not use Rebinyn®? Do not use Rebinyn® if you: are allergic to Factor IX or any of the other ingredients of Rebinyn®. are allergic to hamster proteins. What should I tell my healthcare provider before using Rebinyn®? Tell your healthcare provider if you: have or have had any medical conditions. take any medicines, including non-prescription medicines and dietary supplements. are nursing, pregnant, or plan to become pregnant. have been told you have inhibitors to Factor IX. How should I use Rebinyn®? Rebinyn® is given as an infusion into the vein. Call your healthcare provider right away if your bleeding does not stop after taking Rebinyn®. Do not stop using Rebinyn® without consulting your healthcare provider. What are the possible side effects of Rebinyn®? Common side effects include infusion site reaction (bruising, bleeding, swelling, pain, or redness), itching, and rash. Your body can also make antibodies called “inhibitors” against Factor IX, including Rebinyn®, which may stop Rebinyn® from working properly. Your healthcare provider may need to test your blood for inhibitors from time to time. Call your healthcare provider right away or get emergency treatment right away if you get, for example, any of the following signs of an allergic reaction: hives, chest tightness, wheezing, difficulty breathing, and/or swelling of the face. You may be at an increased risk of forming blood clots in your body, especially if you have risk factors for developing blood clots. Call your healthcare provider if you have chest pain, difficulty breathing, leg tenderness, or swelling. Animals given repeat doses of Rebinyn® showed Polyethylene Glycol (PEG) in certain cells in the brain. The potential human implications of these animal tests are unknown. Please click here for Rebinyn® Prescribing Information. Rebinyn® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 0 |
| /help/contact-reps.html | 0 | 0 |
| /safety-considerations.html | 0 | 0 |
| /why/high-factor-levels.html | 1 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Rebinyn has 4.3 points more BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Rebinyn (rebinyn.com)
Rebinyn delivers a high-substance clinical message trapped in a low-substance marketing shell. While the clinical data is robust and specific, the site’s technical implementation—specifically the lack of schema and the presence of unverified trust signals—creates a moderate BS profile typical of large pharma products prioritizing compliance over digital transparency.
Immediately implement Organization and MedicalWebPage schema to anchor the brand’s authority and verify clinical claims. Replace the repetitive ‘Stay in the Know’ H2 tags with descriptive, substance-led headers that highlight specific trial findings. Provide direct outbound links to the specific peer-reviewed studies or the ClinicalTrials.gov registry entries to move from trust theatre to verified proof. Reduce the frequency of the ‘unexpected’ tagline in favor of more granular pharmacokinetic data in the primary heading hierarchy.
The content strictly adheres to the Medical/Pharma category, characterized by extensive mandatory Safety Information, regulatory indications, and clinical trial data references. The presence of terms like Coagulation Factor IX (Recombinant) and GlycoPEGylated confirms a high-fidelity industry match.
“The score of 45 is primarily driven by the total lack of structured data (Step 5) and the detection of unverified trust signals (Step 3). While the information density is high regarding clinical facts, the heavy repetition of marketing taglines (Step 1) prevents a lower BS score.”
This training module utilizes a snapshot of public data from Rebinyn, captured on June 19, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Rebinyn: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://rebinyn.com to view the most current version of its content and learn from the source what this company is about and what it offers.